Logan Capital Management’s Gilead Sciences GILD Stock Holding History

Logan Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,204	Closed	-$308K	–	465
2024 Q1	$308K	Buy	4,204 +2	+0%	+$154	0.01%	270
2023 Q4	$340K	Buy	4,202 +202	+5%	+$15.7K	0.02%	266
2023 Q3	$300K	Hold	4,000	–	–	0.02%	264
2023 Q2	$308K	Hold	4,000	–	–	0.01%	260
2023 Q1	$332K	Hold	4,000	–	–	0.02%	271
2022 Q4	$343K	Hold	4,000	–	–	0.02%	265
2022 Q3	$247K	Hold	4,000	–	–	0.01%	269
2022 Q2	$247K	Hold	4,000	–	–	0.01%	271
2022 Q1	$238K	Hold	4,000	–	–	0.01%	275
2021 Q4	$290K	Hold	4,000	–	–	0.01%	275
2021 Q3	$279K	Hold	4,000	–	–	0.01%	276
2021 Q2	$275K	Hold	4,000	–	–	0.01%	273
2021 Q1	$259K	Hold	4,000	–	–	0.01%	268
2020 Q4	$233K	Hold	4,000	–	–	0.01%	296
2020 Q3	$253K	Sell	4,000 -50	-1%	-$3.47K	0.01%	342
2020 Q2	$312K	Buy	4,050 +50	+1%	+$3.83K	0.02%	268
2020 Q1	$299K	Hold	4,000	–	–	0.02%	283
2019 Q4	$260K	Hold	4,000	–	–	0.01%	281
2019 Q3	$254K	Hold	4,000	–	–	0.02%	280
2019 Q2	$270K	Hold	4,000	–	–	0.02%	277
2019 Q1	$260K	Hold	4,000	–	–	0.02%	278
2018 Q4	$250K	Sell	4,000 -204	-5%	-$14.3K	0.02%	263
2018 Q3	$325K	Buy	4,204 +144	+4%	+$10.9K	0.02%	261
2018 Q2	$287K	Hold	4,060	–	–	0.02%	263
2018 Q1	$307K	Hold	4,060	–	–	0.02%	254
2017 Q4	$291K	Sell	4,060 -60	-1%	-$4.56K	0.02%	255
2017 Q3	$334K	Buy	4,120 +53	+1%	+$4.05K	0.02%	248
2017 Q2	$288K	Sell	4,067 -135	-3%	-$8.98K	0.02%	250
2017 Q1	$286K	Sell	4,202 -156	-4%	-$11K	0.02%	247
2016 Q4	$312K	Sell	4,358 -48,065	-92%	-$3.57M	0.03%	251
2016 Q3	$4.15M	Sell	52,423 -604	-1%	-$49.1K	0.34%	79
2016 Q2	$4.42M	Sell	53,027 -3,130	-6%	-$278K	0.37%	71
2016 Q1	$5.16M	Buy	56,157 +834	+2%	+$75.2K	0.41%	67
2015 Q4	$5.6M	Sell	55,323 -441	-0.8%	-$45.9K	0.45%	61
2015 Q3	$5.47M	Buy	55,764 +432	+0.8%	+$48K	0.46%	63
2015 Q2	$6.48M	Sell	55,332 -633	-1%	-$69.2K	0.48%	63
2015 Q1	$5.49M	Buy	55,965 +4,240	+8%	+$431K	0.39%	72
2014 Q4	$4.88M	Buy	51,725 +40,725	+370%	+$4.21M	0.35%	79
2014 Q3	$1.17M	Sell	11,000 -2,000	-15%	-$196K	0.08%	130
2014 Q2	$1.08M	Hold	13,000	–	–	0.08%	133
2014 Q1	$921K	Hold	13,000	–	–	0.07%	156
2013 Q4	$976K	Sell	13,000 -3,000	-19%	-$209K	0.07%	158
2013 Q3	$1M	Buy	16,000 +3,000	+23%	+$179K	0.08%	140
2013 Q2	$667K	Buy	+13,000	New	+$678K	0.05%	161

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Logan Capital Management's GILD Position: Q2 2024 in Review

Logan Capital Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 4,204 shares — an estimated $308K sold.

Logan Capital Management first reported a position in GILD in Q2 2013 and held it in 44 quarters. The position peaked at $6.48M in Q2 2015. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

Logan Capital Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
Logan Capital Management sold 4,204 Gilead Sciences shares in Q2 2024, an estimated $308K.
Logan Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 44 quarters.
Logan Capital Management's Gilead Sciences position peaked at $6.48M in Q2 2015.
1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Logan Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.